Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell Carcinoma
Clinical trial NCT06470217 · RECRUITING
Trial details
- NCT number
- NCT06470217
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-19
- Primary completion
- 2025-06-19
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.